Atherosclerosis
Volume 203, Issue 2 , Pages 483-488 , April 2009

Rapid improvement of carotid plaque echogenicity within 1 month of pioglitazone treatment in patients with acute coronary syndrome

Received 30 March 2008 ,Revised 4 July 2008 ,Accepted 8 July 2008.

References 

  1. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915–922
  2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–372
  3. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women the Framingham study. JAMA. 1988;260:3456–3460
  4. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954–960
  5. Yki-Järvinen H, Thiazolidinediones . N Engl J Med. 2004;351:1106–1118
  6. Libby P, Plutzky J. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol. 2007;99:27B–40B
  7. Erdmann E, et al. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. J Am Coll Cardiol. 2007;49:1772–1780
  8. Langenfeld MR, Forst T, Hohberg C, et al. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation. 2005;111:2525–2531
  9. Sidhu JS, Kaposzta Z, Markus HS, Kaski JC. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol. 2004;24:930–934
  10. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087–1099
  11. Kern MJ, Meier B. Evaluation of culprit plaque and physiological significance of coronary atherosclerotic narrowings. Circulation. 2001;103:3142–3149
  12. Grønholdt ML, Nordestgaard BG, Bentzon J, et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg. 2002;35:137–145
  13. Shepard RK, Miller JG, Wickline SA. Quantification of atherosclerotic plaque composition in cholesterol-fed rabbits with 50-MHz acoustic microscopy. Arterioscler Thromb. 1992;12:1227–1234
  14. Watanabe K, Sugiyama S, Kugiyama K, et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol. 2005;46:2022–2030
  15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5–S20
  16. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2000;36:970–1062
  17. Takano H, Obata JE, Kodama Y, et al. Adiponectin is released from the heart in patients with heart failure. Int J Cardiol. 2008;[Epub ahead of print]
  18. Schminke U, Hilker L, Motsch L, Griewing B, Kessler C. Volumetric assessment of plaque progression with 3-dimensional ultrasonography under statin therapy. J Neuroimaging. 2002;12:245–251
  19. Tegos TJ, Kalomiris KJ, Sabetai MM, Kalodiki E, Nicolaides AN. Significance of sonographic tissue and surface characteristics of carotid plaques. Am J Neuroradiol. 2001;22:1605–1612
  20. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–1792
  21. Thorp E, Kuriakose G, Shah YM, Gonzalez FJ, Tabas I. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice. Circulation. 2007;116:2182–2190

PII: S0021-9150(08)00508-X

doi: 10.1016/j.atherosclerosis.2008.07.023

Atherosclerosis
Volume 203, Issue 2 , Pages 483-488 , April 2009

Article Tools

* Image Usage & Resolution